Increased susceptibility to colitis and colorectal tumors in mice lacking core 3–derived O-glycans
Open accessThe DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index.
Abstract
Altered intestinal O-glycan expression has been observed in patients with ulcerative colitis and colorectal cancer, but the role of this alteration in the etiology of these diseases is unknown. O-glycans in mucin core proteins are the predominant components of the intestinal mucus, which comprises part of the intestinal mucosal barrier. Core 3–derived O-glycans, which are one of the major types of O-glycans, are primarily expressed in the colon. To investigate the biological function of core 3–derived O-glycans, we engineered mice lacking core 3 β1,3-N-acetylglucosaminyltransferase (C3GnT), an enzyme predicted to be important in the synthesis of core 3–derived O-glycans. Disruption of the C3GnT gene eliminated core 3–derived O-glycans. C3GnT-deficient mice displayed a discrete, colon-specific reduction in Muc2 protein and increased permeability of the intestinal barrier. Moreover, these mice were highly susceptible to experimental triggers of colitis and colorectal adenocarcinoma. These data reveal a requirement for core 3–derived O-glycans in resistance to colonic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The importance of sufficiently complex mucin glycans was demonstrated in studies of mice with truncated glycans as found in O-glycan core 1 or core 3 deficient mice 19, 28.”
From The composition of the gut microbiota shapes the colon mucus barrier (2015) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Varki, A. P., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., & Etzler, M. E. (1999) · Cited by 2,384
Self-citationNadkarni, M. A., Martin, F. E., Jacques, N. A., & Hunter, N. (2002) · Microbiology · doi:10.1099/00221287-148-1-257 · Cited by 1,938
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542 · cited 1×
“This distinguishes C3GnT−/− mice from models of TH1 or TH17 colitis (42, 49, 50).”
BackgroundLinking Colorectal Cancer to Wnt Signaling
Bienz, M., & Clevers, H. (2000) · Cell · doi:10.1016/s0092-8674(00)00122-7 · Cited by 1,515 · cited 2×
“The altered expression of β-catenin/TCF-4, c-myc, and cyclin D1 observed during carcinogenesis in C3GnT−/− mice relates its molecular pathogenesis to that commonly observed in human colorectal cancer (35).”
BackgroundThe Immunology of Mucosal Models of Inflammation
Strober, W., Fuss, I. J., & Blumberg, R. S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064816 · Cited by 1,304 · cited 3×
“The relatively modest immune infl ammatory components in Muc2−/− and C3GnT−/− mice suggest that defi ciencies in mucus layer integrity alone are insuffi cient to drive immune colitis, without the contribution of additional traits aff ecting innate immune function or immunoregulation (42).”
BackgroundImmunity, Inflammation, and Allergy in the Gut
MacDonald, T. T., & Monteleone, G. (2005) · Science · doi:10.1126/science.1106442 · Cited by 1,035 · cited 1×
“Products of these and other immune cell types can induce abnormal epithelial cell growth and survival that contribute to carcinogenesis (9, 52).”
BackgroundColorectal Cancer in Mice Genetically Deficient in the Mucin Muc2
Velcich, A., Yang, W., Heyer, J., Fragale, A., Nicholas, C., Viani, S., Kucherlapati, R., Lipkin, M., Yang, K., & Augenlicht, L. (2002) · Science · doi:10.1126/science.1069094 · Cited by 936 · cited 8×
“In another experiment, PAS (Sigma-Aldrich) and Alcian blue (Newcomer Supply) were used to stain general intestinal carbohydrate moieties.”
BackgroundMethodInfluentialFuss, I. J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19836 · Cited by 797 · cited 1×
“This distinguishes C3GnT−/− mice from models of TH1 or TH17 colitis (42, 49, 50).”
BackgroundTanaka, T., Kohno, H., Suzuki, R., Yamada, Y., Sugie, S., & Mori, H. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01386.x · Cited by 729 · cited 7×
“In another experiment, PAS (Sigma-Aldrich) and Alcian blue (Newcomer Supply) were used to stain general intestinal carbohydrate moieties.”
BackgroundMethodInfluentialTGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726
Martin, H. M., Campbell, B. J., Hart, C. A., Mpofu, C., Nayar, M., Singh, R., Englyst, H., Williams, H. F., & Rhodes, J. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.054 · Cited by 716 · cited 1×
“Enhanced Escherichia coli adherence and invasion has been found in Crohn’s disease and colon cancer, presumably because of altered mucosal glycosylation (46).”
BackgroundPanwala, C. M., Jones, J. C., & Viney, J. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5733 · Cited by 567
Z/AP, a Double Reporter for Cre-Mediated Recombination
Lobe, C. G., Koop, K. E., Kreppner, W., Lomeli, H., Gertsenstein, M., & Nagy, A. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9209 · Cited by 528
All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases
Ten Hagen, K. G. (2003) · Glycobiology · doi:10.1093/glycob/cwg007 · Cited by 498 · cited 2×
“Our data suggest that substrate specifi cities of the glycosyltransferases for core 1 or core 3 O-glycans may be determined not only by the Tn antigen, but also by other factors, such as rate-limiting enzymatic activity, sequence of the acceptor peptide, or neighboring glycosylation, as exhibited by some of the UDP-Ga…”
BackgroundMucins and mucin binding proteins in colorectal cancer
Byrd, J. C., & Bresalier, R. S. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025815113599 · Cited by 490 · cited 3×
“Interestingly, similarly altered O-glycans are seen in >90% of colorectal cancers, which have a close association with ulcerative colitis (6, 17, 18).”
BackgroundJu, T., & Cummings, R. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262438199 · Cited by 487
Self-citationElson, C. O., Cong, Y., McCracken, V. J., Dimmitt, R. A., Lorenz, R. G., & Weaver, C. T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00291.x · Cited by 469 · cited 1×
“IBD is generally recognized as an immunemediated disorder resulting from an abnormal interaction between colonic microfl ora and mucosal immune cells in a genetically susceptible host (14, 16).”
BackgroundContamination and Sensitivity Issues with a Real-Time Universal 16S rRNA PCR
Corless, C. E., Guiver, M., Borrow, R., Edwards-Jones, V., Kaczmarski, E. B., & Fox, A. J. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.5.1747-1752.2000 · Cited by 452
Furuta, G. T., Turner, J. R., Taylor, C. T., Hershberg, R. M., Comerford, K., Narravula, S., Podolsky, D. K., & Colgan, S. P. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1027 · Cited by 449 · cited 1×
“mine if the loss of O-glycans increases intestinal barrier permeability (57).”
BackgroundClayburgh, D. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24970 · Cited by 426
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214459 · Cited by 418
Zolotarevsky, Y., Hecht, G., Koutsouris, A., Gonzalez, D. E., Quan, C., Tom, J., Mrsny, R. J., & Turner, J. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.34235 · Cited by 389 · cited 1×
“Moreover, the infl ammatory products of these cells have been mechanistically linked to increased epithelial permeability through activation of epithelial myosin light chain kinase (47, 48).”
BackgroundMucins in the gastrointestinal tract in health and disease
Corfield, A. (2001) · Frontiers in Bioscience · doi:10.2741/corfield · Cited by 344
Blair, S. A., Kane, S. V., Clayburgh, D. R., & Turner, J. R. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700373 · Cited by 299 · cited 1×
“Moreover, the infl ammatory products of these cells have been mechanistically linked to increased epithelial permeability through activation of epithelial myosin light chain kinase (47, 48).”
BackgroundCloning and Expression of Human Core 1 β1,3-Galactosyltransferase
Ju, T., Brewer, K., D'Souza, A., Cummings, R. D., & Canfield, W. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109060200 · Cited by 290
Self-citationMorteau, O., Morham, S. G., Sellon, R., Dieleman, L. A., Langenbach, R., Smithies, O., & Sartor, R. B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci6899 · Cited by 275
Chaperone mutation in Tn syndrome
Ju, T., & Cummings, R. D. (2005) · Nature · doi:10.1038/4371252a · Cited by 271 · cited 1×
“Alterations in the structure or expression of glycosyltransferases have been implicated in the etiology of several human diseases (1, 2, 43).”
BackgroundSelf-citationMesenteric lymph nodes at the center of immune anatomy
Macpherson, A. J., & Smith, K. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060227 · Cited by 260 · cited 1×
“Mesenteric bacterial translocation is associated with traffi cking of bacteria-bearing dendritic cells from the mucosa, typically after Toll-like receptor sensing or other immune activation (27, 28).”
BackgroundMyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis
Araki, A., Kanai, T., Ishikura, T., Makita, S., Uraushihara, K., Iiyama, R., Totsuka, T., Takeda, K., Akira, S., & Watanabe, M. (2005) · Journal of Gastroenterology · doi:10.1007/s00535-004-1492-9 · Cited by 239
Macfarlane, S., Woodmansey, E. J., & Macfarlane, G. T. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.11.7483-7492.2005 · Cited by 234
Xia, L., Sperandio, M., Yago, T., McDaniel, J. M., Cummings, R. D., Pearson-White, S., Ley, K., & McEver, R. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14151 · Cited by 230 · cited 1×
“1, B and C) using previously described methods (22, 23).”
MethodSelf-citationSun, J., Blaskovich, M. A., Knowles, D. B., Qian, Y., Ohkanda, J., Bailey, R. D., Hamilton, A. D., & Sebti, S. M. (1999) · PubMed · Cited by 213
Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1–derived O-glycans
Xia, L., Ju, T., Westmuckett, A., An, G., Ivanciu, L., McDaniel, J. M., Lupu, F., Cummings, R. D., & McEver, R. P. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200311112 · Cited by 187 · cited 6×
“electron microscopy was performed as previously described (22).”
BackgroundMethodResultInfluentialSelf-citationWei, B., Velazquez, P., Turovskaya, O., Spricher, K., Aranda, R., Kronenberg, M., Birnbaumer, L., & Braun, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409449102 · Cited by 176 · cited 1×
“To further understand the immunological features of DSS-induced colitis in C3GnT−/− mice, we evaluated intracellular production of the cytokines IL-2, IL-17, IFN-γ, and TNF-α in splenocytes (30).”
MethodSelf-citationIwai, T., Inaba, N., Naundorf, A., Zhang, Y., Gotoh, M., Iwasaki, H., Kudo, T., Togayachi, A., Ishizuka, Y., Nakanishi, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112457200 · Cited by 176 · cited 6×
“RESULTS Molecular characterization of the murine C3GnT gene A Mus musculus chromosome 7 genomic contig (NT_039433) that contains the C3GnT gene and a 2,370-bp, full-length murine cDNA sequence (XM_195661) were identifi ed by BLASTN searches using the published human C3GnT nucleotide sequence (19).”
BackgroundMethodInfluentialThe primary defect in experimental ileitis originates from a nonhematopoietic source
Olson, T. S., Reuter, B. K., Scott, K. G.-E., Morris, M. A., Wang, X.-M., Hancock, L. N., Burcin, T. L., Cohn, S. M., Ernst, P. B., Cominelli, F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050407 · Cited by 172 · cited 1×
“A recent study suggested that dysfunction of the intestinal epithelial barrier is the primary cause of SAMP ileitis susceptibility (45).”
BackgroundAltered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis
Xia, B., Royall, J. A., Damera, G., Sachdev, G. P., & Cummings, R. D. (2005) · Glycobiology · doi:10.1093/glycob/cwi061 · Cited by 171 · cited 1×
“Disruption of the C3GnT gene eliminates core 3–derived O-glycans and exposes the Tn antigen in murine colon We used matrix-assisted laser desorption/ionization time-offl ight mass spectrometry (MALDI-TOF-MS) to defi ne the O-glycan structures in C3GnT+/+ and C3GnT−/− colon (24).”
MethodSelf-citationGlycoprotein Composition of Colonic Mucosa
Podolsky, D. K., & Isselbacher, K. J. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80055-4 · Cited by 168
Iwai, T., Kudo, T., Kawamoto, R., Kubota, T., Togayachi, A., Hiruma, T., Okada, T., Kawamoto, T., Morozumi, K., & Narimatsu, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407983102 · Cited by 159
Ott, S. J., Musfeldt, M., Ullmann, U., Hampe, J., & Schreiber, S. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2566-2572.2004 · Cited by 148
Resta-Lenert, S., Smitham, J., & Barrett, K. E. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00395.2004 · Cited by 129
Turnbull, E. L., Yrlid, U., Jenkins, C. D., & MacPherson, G. G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1374 · Cited by 123 · cited 1×
“Mesenteric bacterial translocation is associated with traffi cking of bacteria-bearing dendritic cells from the mucosa, typically after Toll-like receptor sensing or other immune activation (27, 28).”
BackgroundImproved procedure for the isolation of functionally active lymphoid cells from the murine intestine
van der Heijden, P. J., & Stok, W. (1987) · Journal of Immunological Methods · doi:10.1016/0022-1759(87)90285-7 · Cited by 113
Rhodes, J. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91563-9 · Cited by 110
Maggio‐Price, L., Bielefeldt‐Ohmann, H., Treuting, P. M., Iritani, B. M., Zeng, W., Nicks, A., Tsang, M., Shows, D. M., Morrissey, P., & Viney, J. L. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62489-3 · Cited by 93 · cited 1×
“Accelerated colorectal tumorigenesis in C3GnT−/− mice after azoxymethane (AOM) and DSS treatment Patients with ulcerative colitis exhibit increased risk of colorectal cancer (32, 33).”
BackgroundTargeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when
Sartor, B. R. (2003) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200307000-00006 · Cited by 93 · cited 1×
“Products of these and other immune cell types can induce abnormal epithelial cell growth and survival that contribute to carcinogenesis (9, 52).”
BackgroundAltered mucin expression in the gastrointestinal tract: a review
Jass, J. R., & Walsh, M. D. (2001) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2001.tb00169.x · Cited by 88 · cited 2×
“Interestingly, similarly altered O-glycans are seen in >90% of colorectal cancers, which have a close association with ulcerative colitis (6, 17, 18).”
BackgroundStevceva, L., Pavli, P., Husband, A. J., & Doe, W. F. (2001) · BMC Clinical Pathology · doi:10.1186/1472-6890-1-3 · Cited by 77 · cited 1×
“C3GnT−/− mice are highly susceptible to dextran sodium sulfate (DSS)–induced colitis DSS is a chemical commonly used to induce experimental colitis (29).”
BackgroundGlycoproteins and Human Disease
Brockhausen, I., & Kuhns, W. J. (1997) · Medical intelligence unit · doi:10.1007/978-3-662-21960-7 · Cited by 64 · cited 5×
“Alterations in the structure or expression of glycosyltransferases have been implicated in the etiology of several human diseases (1, 2, 43).”
BackgroundInfluentialWilliams, C. N., Kocher, K., Lander, E. S., Daly, M. J., & Rioux, J. D. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200211000-00001 · Cited by 63 · cited 1×
“No genes regulating O-glycosylation have yet been identifi ed in the known IBD loci (44).”
BackgroundItoh, H., Beck, P. L., Inoue, N., Xavier, R., & Podolsky, D. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6211 · Cited by 62
Alterations in Muc2 biosynthesis and secretion during dextran sulfate sodium-induced colitis
Renes, I. B., Boshuizen, J. A., Van Nispen, D. J. P. M., Bulsing, N. P., Büller, H. A., Dekker, J., & Einerhand, A. W. C. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00229.2001 · Cited by 54 · cited 1×
“The expression of Muc2, which is the primary component of colonic mucus layer, is lower in patients with active ulcerative colitis (6, 40).”
BackgroundPodolsky, D. K., & Fournier, D. A. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90494-5 · Cited by 50
ten Hove, T., Drillenburg, P., Wijnholds, J., Velde, A. A. T., & van Deventer, S. J. H. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1019629013945 · Cited by 45
Banner, K. H., Cattaneo, C., Net, J.-L. L., Popovic, A., Collins, D., & Gale, J. D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705982 · Cited by 44
Altered expression of mucins throughout the colon in ulcerative colitis.
Smithson, J. E., Campbell, A., Andrews, J. M., Milton, J. D., Pigott, R., & Jewell, D. P. (1997) · Gut · doi:10.1136/gut.40.2.234 · Cited by 44
Challenges in IBD Research: Updating the Scientific Agendas
Elson, C. O., Sartor, R. B., Targan, S. R., & Sandborn, W. J. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200305000-00001 · Cited by 32 · cited 1×
“IBD is generally recognized as an immunemediated disorder resulting from an abnormal interaction between colonic microfl ora and mucosal immune cells in a genetically susceptible host (14, 16).”
BackgroundAltered Immune System Glycosylation Causes Colitis in α1,2-Fucosyltransferase Transgenic Mice
Brown, S. J., Miller, A. M., Cowan, P. J., Slavin, J., Connell, W. R., Moore, G. T., Bell, S., Elliott, P. R., Desmond, P. V., & d’Apice, A. J. F. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200409000-00008 · Cited by 29 · cited 1×
“Glycosylation regulates lymphocyte traffi cking, and mice transgenic for human α1,2-fucosyltransferase exhibit colitis as a result of defective T cell development resulting from altered lymphocyte glycosylation (51).”
BackgroundColonic mucus and ulcerative colitis.
Rhodes, J. M. (1997) · Gut · doi:10.1136/gut.40.6.807 · Cited by 27
Colorectal cancer in inflammatory bowel disease: Molecular and clinical considerations
Rubin, D. T., & Parekh, N. K. (2006) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-006-0040-5 · Cited by 25
Mucosal Epithelium in Health and Disease
Ponda, P., & Mayer, L. (2005) · Current Molecular Medicine · doi:10.2174/1566524054863933 · Cited by 22
Cited by
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
The gut microbiota--masters of host development and physiology
Sommer, F., & Bäckhed, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2974 · Cited by 3,681
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“Disruption of this layer by genetically altering mucin backbones, O-linked glycosyltransferases (or key chaperones like Cosmc) can have very serious consequences, including inflammation and carcinogenesis associated with microbial invasion (453) (454) (455) (456) .”
BackgroundThe inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
Johansson, M. E. V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., & Hansson, G. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803124105 · Cited by 2,200
“Sampleswereanalyzed by PCR with universal primers directed against a region of the 16S rRNA gene common to most bacteria: set1 (forward 5 -CCATGAAGTCGGAATCGCTAG-3 and reverse, 5 -ACTCCCATGGTGTGACGG-3 ) (bp 1302–1394 in bacteria EU622773) and set2 (forward, 5 -TCCTACGGGAGGCAGCAGT-3 ; reverse, 5 -GGACTACCAGGGTATCTAATCCT…”
InfluentialGlycosylation in health and disease
Reily, C., Stewart, T. J., Renfrow, M. B., & Novak, J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0129-4 · Cited by 2,075
Metadata
- Authors
- An, G., Wei, B., Xia, B., McDaniel, J. M., Ju, T., Cummings, R. D., Braun, J., & Xia, L.
- Affiliations
- Oklahoma Medical Research Foundation (US)
- University of California, Los Angeles (US)
- Emory University (US)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-05-21
- Volume
- 204
- Issue
- 6
- Pages
- 1417-1429
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118614
- OpenAlex
- W2047595952
- Cited by
- 352
- References
- 65
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 16 · 2023: 17 · 2022: 25 · 2021: 26 · 2020: 20 · 2019: 14 · 2018: 20 · 2017: 9 · 2016: 15 · 2015: 21 · 2014: 28 · 2013: 16 · 2012: 20
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL085607)
- National Cancer Institute (P30CA016042)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK069434, R01DK069434)
- National Center for Research Resources (RR 018758, P20RR018758)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- mucin core proteins, MUC2, intestinal mucus, intestinal permeability, colitis, colorectal adenocarcinoma, ulcerative colitis, colorectal cancer, knockout mice, glycosylation
- MeSH terms
- Animals, Colitis, Colon, Disease Susceptibility, Immunohistochemistry, Mucins, Polysaccharides, Immunoblotting, Colorectal Neoplasms, N-Acetylglucosaminyltransferases, DNA Primers, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Microscopy, Electron, Transmission, Mice, Mucin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.